/PRNewswire/ ACELYRIN, INC., a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in.
Golden Ticket programme is open to early-stage life sciences companies and biotech start-ups which are focusing on cutting edge therapies - News - PharmaTimes